Ethema Health CORP (GRST) — SEC Filings

Q: What are the key financial highlights for Ethema Health CORP?

Key financial highlights for Ethema Health CORP are extracted from the most recent 10-K or 10-Q filings, including revenue, net income, EPS, debt-to-equity, cash position, and operating margin.

Q: Who are the key executives at Ethema Health CORP?

Key executives at Ethema Health CORP are identified from SEC filings including 10-K annual reports, proxy statements, and insider trade forms.

Q: What are the main risk factors for Ethema Health CORP stock?

Risk factors for Ethema Health CORP (GRST) are assessed from SEC filings using AI analysis. Each filing is categorized as high, medium, or low risk based on disclosed risk factors and financial indicators.

Q: What are recent predictions and forward guidance from Ethema Health CORP?

Forward-looking statements and predictions from Ethema Health CORP are extracted from SEC filings including earnings reports, annual reports, and current event filings.

Latest SEC filings for Ethema Health CORP. Recent 10-Q filing on Dec 3, 2025. AI-decoded analysis of earnings, risk factors, and insider trades.

View Ethema Health CORP on SEC EDGAR

Overview

Ethema Health CORP (GRST) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 10-Q filed on Dec 3, 2025: ETHEMA HEALTH Corp (GRST) reported a significant increase in revenue for the nine months ended September 30, 2025, reaching $13,952,597, a substantial rise from $4,550,200 in the same period of 2024. The company achieved a net income of $66,136 for the three months ended September 30, 2025, a notabl

Sentiment Summary

Across 14 filings, the sentiment breakdown is: 1 bullish, 3 bearish, 9 neutral, 1 mixed. The dominant filing sentiment for Ethema Health CORP is neutral.

Filing Type Overview

Ethema Health CORP (GRST) has filed 6 10-Q, 2 10-K, 6 8-K with the SEC between Feb 2024 to Dec 2025.

Filings by Year

2025 · 2024

Recent Filings (14)

ETHEMA HEALTH Swings to Q3 Profit Amidst Aggressive Expansion — 10-Q · Dec 3, 2025 Risk: high
ETHEMA HEALTH Corp (GRST) reported a significant increase in revenue for the nine months ended September 30, 2025, reaching $13,952,597, a substantial rise from
Ethema Health Revenue Soars 202% Amidst Widening Losses — 10-Q · Nov 3, 2025 Risk: high
ETHEMA HEALTH Corp (GRST) reported a significant increase in revenue for the six months ended June 30, 2025, reaching $8,423,195, up from $2,790,200 in the same
Ethema Health's Revenue Soars 170% Amidst Widening Losses — 10-Q · Oct 17, 2025 Risk: high
ETHEMA HEALTH Corp (GRST) reported a significant increase in revenues to $3,517,775 for the three months ended March 31, 2025, up from $1,300,100 in the prior-y
ETHEMA HEALTH Posts Widening Loss Amid Zero Revenue, Eyes Expansion — 10-K · May 23, 2025 Risk: high
ETHEMA HEALTH Corp (GRST) reported a net loss of $1,000,000 for the fiscal year ended December 31, 2024, a significant increase from the $500,000 net loss in 20
8-K Filing — 8-K · Jan 23, 2025
ETHEMA HEALTH Corp. Files 8-K on Shareholder Votes — 8-K · Jan 10, 2025 Risk: low
ETHEMA HEALTH Corp. (formerly Greenstone Healthcare Corp and Nova Natural Resources Corp) filed an 8-K on January 10, 2025, reporting on matters submitted to a
ETHEMA HEALTH Corp Files Q3 2024 10-Q — 10-Q · Nov 14, 2024 Risk: medium
ETHEMA HEALTH Corp filed its 10-Q for the period ending September 30, 2024. The company, formerly known as GREENESTONE HEALTHCARE CORP, is based in West Palm Be
Ethema Health Corp. Enters Material Definitive Agreement — 8-K · Oct 29, 2024 Risk: medium
ETHEMA HEALTH Corp. entered into a material definitive agreement on October 22, 2024. The company, formerly known as GREENESTONE HEALTHCARE CORP and NOVA NATURA
ETHEMA HEALTH Corp Files Q2 2024 10-Q — 10-Q · Aug 19, 2024 Risk: low
ETHEMA HEALTH Corp filed its 10-Q for the period ending June 30, 2024. The filing details financial information for the second quarter of 2024, including balanc
ETHEMA HEALTH Corp. Files 8-K: Material Agreement & Equity Sales — 8-K · Jul 12, 2024 Risk: medium
On July 8, 2024, ETHEMA HEALTH Corp. entered into a material definitive agreement. The company also reported on unregistered sales of equity securities and file
Ethema Health Corp. Reports Asset Acquisition and Financial Obligations — 8-K · Jun 18, 2024 Risk: medium
On June 12, 2024, ETHEMA HEALTH Corp. (formerly GREENESTONE HEALTHCARE CORP and NOVA NATURAL RESOURCES CORP) reported the completion of an acquisition or dispos
ETHEMA HEALTH Corp Files Q1 2024 10-Q — 10-Q · May 31, 2024 Risk: low
ETHEMA HEALTH Corp filed its 10-Q for the period ending March 31, 2024. The company, formerly known as GREENESTONE HEALTHCARE CORP, is incorporated in Colorado
ETHEMA HEALTH Corp Files 2023 Annual Report on Form 10-K — 10-K · May 7, 2024 Risk: low
ETHEMA HEALTH Corp (GRST) filed a Annual Report (10-K) with the SEC on May 7, 2024. ETHEMA HEALTH Corp (formerly GREENESTONE HEALTHCARE CORP) filed its 2023 10-
Ethema Health Secures Revolving Line of Credit with Testing 123 — 8-K · Feb 7, 2024
On February 1, 2024, Ethema Health Corporation, along with American Treatment Holdings Inc. and Evernia Health Center LLC, secured a revolving line of credit ag

Risk Profile

Risk Assessment: Of GRST's 12 recent filings, 4 were flagged as high-risk, 4 as medium-risk, and 4 as low-risk. The overall risk profile suggests relatively low risk with generally favorable filings.

Financial Highlights

Key financial metrics from Ethema Health CORP's most recent 10-Q filing (Dec 3, 2025):

Revenue: $13,952,597
Net Income: $66,136
EPS: N/A
Debt-to-Equity: N/A
Cash Position: $114,030
Operating Margin: N/A
Total Assets: $30,267,418
Total Debt: $38,840,475

Key Executives

John Elam
Shawn Leon

Industry Context

ETHEMA HEALTH Corp operates within the healthcare sector, specifically focusing on addiction treatment services. This industry is characterized by increasing demand due to the ongoing opioid crisis and mental health challenges. However, it is also subject to stringent regulatory oversight, complex reimbursement structures from third-party payors (both governmental and commercial), and significant competition from other providers.

Top Tags

Healthcare Services (4) · Addiction Treatment (3) · Acquisitions (3) · Net Loss (3) · 10-Q (3) · healthcare (3) · financials (3) · High Debt (2) · Related Party Transactions (2) · Revenue Growth (2)

Key Numbers

Revenue for nine months ended Sept 30, 2025: $13,952,597 — Increased from $4,550,200 in 2024, a 206% increase
Net income for three months ended Sept 30, 2025: $66,136 — Turnaround from a net loss of $(1,000,714) in 2024
Net loss for nine months ended Sept 30, 2025: $(1,114,490) — Improved from $(1,840,192) in 2024
Total assets as of Sept 30, 2025: $30,267,418 — Increased from $12,158,402 at Dec 31, 2024, a 149% increase
Total liabilities as of Sept 30, 2025: $38,840,475 — Increased from $19,616,969 at Dec 31, 2024, a 98% increase
Cash as of Sept 30, 2025: $114,030 — Decreased from $244,771 at Dec 31, 2024, a 53% decrease
Common shares outstanding as of Dec 2, 2025: 7,726,283,805 — High share count indicating potential dilution
Acquisition cost for remaining 25% of ATHI: $1,100,000 — Completed on May 15, 2024
Cash payment for Edgewater Recovery Centers, LLC assets: $250,000 — Paid on January 9, 2025
Accumulated deficit as of Sept 30, 2025: $(45,533,962) — Indicates historical losses
Revenues for six months ended June 30, 2025: $8.42M — Increased 201.9% from $2.79M in 2024
Net loss for six months ended June 30, 2025: $1.18M — Widened from $839,478 in 2024
Accumulated deficit as of June 30, 2025: $45.60M — Increased from $44.42M as of December 31, 2024
Total stockholders' deficit as of June 30, 2025: $8.64M — Increased from $7.46M as of December 31, 2024
Total assets as of June 30, 2025: $28.90M — Increased from $12.16M as of December 31, 2024, largely due to acquisitions

Frequently Asked Questions

What are the latest SEC filings for Ethema Health CORP (GRST)?

Ethema Health CORP has 14 recent SEC filings from Feb 2024 to Dec 2025, including 6 10-Q, 6 8-K, 2 10-K. Each filing includes an AI-generated plain-English summary.

What is the overall sentiment of GRST filings?

Across 14 filings, the sentiment breakdown is: 1 bullish, 3 bearish, 9 neutral, 1 mixed. The dominant sentiment is neutral.

Where can I find Ethema Health CORP SEC filings explained simply?

ReadTheFiling provides AI-powered plain-English summaries of all Ethema Health CORP (GRST) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.

What are the key financial highlights for Ethema Health CORP?

Key financial highlights from Ethema Health CORP's most recent 10-Q include metrics such as revenue, net income, EPS, and debt ratios. Visit the filing detail page for the full breakdown.

What is the investment thesis for GRST?

The investment thesis for GRST includes bull, base, and bear case scenarios derived from AI analysis of recent SEC filings.

Who are the key executives at Ethema Health CORP?

Key executives identified across Ethema Health CORP's filings include John Elam, Shawn Leon.

What are the main risk factors for Ethema Health CORP stock?

Of GRST's 12 assessed filings, 4 were flagged high-risk, 4 medium-risk, and 4 low-risk.

What are recent predictions and forward guidance from Ethema Health CORP?

Forward guidance and predictions for Ethema Health CORP are extracted from SEC filings as they are enriched.